Free Trial

Nature's Sunshine Products, Inc. (NASDAQ:NATR) Shares Sold by Boston Partners

Boston Partners cut its holdings in shares of Nature's Sunshine Products, Inc. (NASDAQ:NATR - Free Report) by 32.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 173,463 shares of the company's stock after selling 82,072 shares during the period. Boston Partners owned about 0.91% of Nature's Sunshine Products worth $2,999,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in NATR. Jump Financial LLC purchased a new stake in Nature's Sunshine Products in the 4th quarter worth approximately $208,000. Williams & Novak LLC purchased a new stake in Nature's Sunshine Products during the fourth quarter worth $201,000. Allspring Global Investments Holdings LLC acquired a new stake in Nature's Sunshine Products during the fourth quarter valued at $139,000. Ritholtz Wealth Management increased its holdings in Nature's Sunshine Products by 34.7% in the fourth quarter. Ritholtz Wealth Management now owns 29,207 shares of the company's stock valued at $505,000 after buying an additional 7,523 shares in the last quarter. Finally, SG Americas Securities LLC acquired a new position in shares of Nature's Sunshine Products in the fourth quarter worth about $125,000. 79.40% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, DA Davidson raised their target price on Nature's Sunshine Products from $21.50 to $24.00 and gave the company a "buy" rating in a research report on Wednesday, March 13th.


View Our Latest Research Report on NATR

Nature's Sunshine Products Price Performance

Shares of NASDAQ:NATR traded down $0.01 during midday trading on Friday, hitting $15.60. The company had a trading volume of 66,946 shares, compared to its average volume of 55,346. Nature's Sunshine Products, Inc. has a twelve month low of $10.69 and a twelve month high of $21.72. The stock has a market cap of $292.19 million, a price-to-earnings ratio of 18.35 and a beta of 0.85. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.33 and a quick ratio of 1.42. The business's 50-day simple moving average is $18.90 and its 200-day simple moving average is $18.01.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last issued its earnings results on Tuesday, March 12th. The company reported $0.45 earnings per share (EPS) for the quarter. The business had revenue of $108.94 million during the quarter. Nature's Sunshine Products had a return on equity of 10.59% and a net margin of 3.69%.

Nature's Sunshine Products Profile

(Free Report)

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.

Featured Articles

Institutional Ownership by Quarter for Nature's Sunshine Products (NASDAQ:NATR)

Should you invest $1,000 in Nature's Sunshine Products right now?

Before you consider Nature's Sunshine Products, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nature's Sunshine Products wasn't on the list.

While Nature's Sunshine Products currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: